Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression of Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07361705
What this trial is testing

Zorifertinib With Osimertinib for NSCLC With Meningeal Progression

Who this might be right for
Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment
Alpha Biopharma (Jiangsu) Co., Ltd. 42
Testing effectiveness (Phase 2)Ended earlyNCT01090830
What this trial is testing

Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Holy Cross Hospital, Florida 7
Testing effectiveness (Phase 2)Study completedNCT03513666
What this trial is testing

Toripalimab+ Pemetrexed Plus Carboplatin in Patients With EGFR-mutation Positive and T790M Negative After Progression on EGFR-TKI Treatment

Who this might be right for
NSCLC
Shanghai Junshi Bioscience Co., Ltd. 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07718737
What this trial is testing

Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Multitude Therapeutics Inc. 512
Early research (Phase 1)UnknownNCT05942508
What this trial is testing

A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy

Who this might be right for
Limited Stage Small Cell Lung CancerNot Progressed After First-line Chemoradiotherapy
Jinming Yu 20
Large-scale testing (Phase 3)Study completedNCT00806923
What this trial is testing

Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 1,044
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07574684
What this trial is testing

Clinical Effects of Alpha-Lipoic Acid in Advanced NSCLC

Who this might be right for
Advanced Non Small Cell Lung Cancer (NSCLC)
Ain Shams University 60
Testing effectiveness (Phase 2)UnknownNCT03865511
What this trial is testing

MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib

Who this might be right for
Non-small Cell Lung Cancer
Nantes University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT03155009
What this trial is testing

The Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 44
Not applicableUnknownNCT05497076
What this trial is testing

The Efficacy and Safety of Dalpiciclib Combined With Third-generation EGFR-TKI in Patients With EGFR Mutation and Meningial Metastasis in Non-small Cell Lung Cancer Progressing Through Third-generation TKI and Platinum-containing Two-drug Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer Confirmed by Histopathology or CytologyThe TNM (8th) Phase is IVWith EGFR Mutations+4 more
Fujian Cancer Hospital 9
Large-scale testing (Phase 3)UnknownNCT02416739
What this trial is testing

Anticancer Activity of Nicotinamide on Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Il Yeong Park, Ph.D. 110
Not applicableActive Not RecruitingNCT05198154
What this trial is testing

CtDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

Who this might be right for
Advanced Lung Non-Small Cell Carcinoma
Fang Wu 100
Testing effectiveness (Phase 2)Ended earlyNCT00773383
What this trial is testing

The Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 35
Large-scale testing (Phase 3)Study completedNCT00312013
What this trial is testing

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

Who this might be right for
Thrombosis, Venous
GlaxoSmithKline 503
Testing effectiveness (Phase 2)Study completedNCT00701558
What this trial is testing

First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Hoffmann-La Roche 20
Not applicableUnknownNCT02397239
What this trial is testing

Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
National Cheng-Kung University Hospital 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07001995
What this trial is testing

Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression

Who this might be right for
Small Cell Lung CancerNon Small Cell Lung CancerNon Small Cell Lung Cancer NSCLC
Hunan Province Tumor Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00503971
What this trial is testing

Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.

Who this might be right for
Non-small Cell Lung Cancer
Spanish Lung Cancer Group 33
Not applicableUnknownNCT05925751
What this trial is testing

Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerNeoadjuvant ChemoimmunotherapyComplete Pathological Response
Shanghai Pulmonary Hospital, Shanghai, China 100
Early research (Phase 1)Ended earlyNCT05443971
What this trial is testing

Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen

Who this might be right for
Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8
Mayo Clinic 4
Next Page